MedTrace Logo

S-100B and Neuron-specific Enolase (NSE) in Spinal Trauma

NCT00980434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2012-04-04

No results posted yet for this study

Summary

The investigators are studying the clinical worth of the serum markers S-100B and NSE in patients with spinal cord injuries e.g. in patients with vertebral fractures. If there is a injury to the neuronal structures these two proteins could be secreted into the serum and add evidence to the severity of the injury.

Conditions

  • Spinal Cord Injury

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Vilmos Vecsei, M.D. Professor · Head of Department

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2011-11-30
Completion
2011-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00980434 on ClinicalTrials.gov